Siemens Healthcare highlighted its Biograph mCT, as well as other technologies, at the annual meeting of the Radiological Society of North America in Chicago last week.
Philips Healthcare unveiled Gemini TF PET/CT and BrightView XCT SPECT/CT scanners at the 2009 Radiological Society of North America annual conference in Chicago last week.
GE Healthcare introduced improvements in predictability, efficiency and confidence across the Discovery PET/CT 600 series portfolio at the 2009 Radiological Society of North America in Chicago last week. The company announced dual-detector capabilities and an enhanced application suite for the Discovery PET/CT 600 series scanners, as well as launched Discovery PET/CT 690 with BrightSpeed Elite CT.
CIOs are concerned about their ability to implement the standards recommended by the Health IT Standards Committee in time to meet currently established deadlines, according to a recent survey conducted by the College of Healthcare Information Management Executives (CHIME).
The Centers for Medicare & Medicaid Services (CMS), in a Nov. 30 draft memorandum, has proposed that “the evidence is not sufficient” to determine that the results of NaF-18 PET imaging to identify bone metastases improve health outcomes of beneficiaries with cancer, and therefore, is looking to stop reimbursements for the procedure.
Research published in the December issue of the Journal of Nuclear Medicine suggests that SPECT, when combined with low-dose CT, can provide an accurate diagnosis for pulmonary embolism.
Written by Lisa Fratt
CHICAGO--Eight years after the Centers for Medicare & Medicaid Services first covered PET for an oncologic application, molecular imaging’s main modality is edging toward more comprehensive coverage. That journey has been a long, slow ride, recalled Valerie Cronin, CNMT, chief operating officer of DENT Neurologic Institute in Buffalo, N.Y., during Tuesday morning’s Molecular Imaging: Here to Stay educational session at the Radiological Society of North America (RSNA) conference.
Written by Lisa Fratt
CHICAGO--Molecular imaging is here to stay, posed David Gilmore, MS, CNMT, program of director nuclear medicine at Beth Israel Deaconess Medical Center in Boston. Yet, molecular imaging continues to evolve and impact the technologist. Gilmore peered into the crystal ball to help techs better understand the coming molecular imaging revolution and its impact on them during a Tuesday morning educational session at the annual 2009 Radiological Society of North America (RSNA) meeting.
Lawson Health Research Institute will receive more than $1 million of the $5.4 million from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada to support research into medical isotope alternatives.
PET strategies are very useful in monitoring the distribution and kinetics of vector-mediated gene expression, as well as the response to therapy in malignant glioma, according to a presentation last week at the Molecular Targets and Cancer Therapeutics (MTCT) conference in Boston.
The use of FDG-PET/CT on patients with obstructive Crohn’s disease can provide physicians with information about whether surgical or medical therapy is the preferred treatment option, according to a study in the November issue of the Journal of Nuclear Medicine.
BOSTON--Novel targeted cancer therapies could benefit from nuclear MR (NMR) and spectroscopy imaging to obtain an early indication of drug efficacy and guide personalized medicine, according to a presentation Tuesday at the Molecular Targets and Cancer Therapeutics (MTCT) conference.
Vertilon has begun production of the SIB232 sensor interface board for fluorescence detection applications including flow cytometry, confocal microscopy, and bioaerosol detection.
The American College of Radiology Imaging Network (ACRIN) is seeking clinical trial sites to study the predictive value FDG-PET/CT staging on clinically-defined negative neck cancer patients.
The U.S. House of Representatives has passed HR 3276—the American Medical Isotopes Production Act of 2009—by a roll call vote of 400-17. The legislation will help to fund projects for producing the medical isotope molybdenum-99 within the United States.
Advanced Medical Isotope Corporation (AMIC) has achieved "encouraging results" from initial tests of its accelerator technology for the domestic production of molybdenum-99 (Mo-99).
The Centers for Medicare & Medicaid Services (CMS) will allow reimbursement for Spectrum Pharmaceuticals radiotherapeutic antibody Zevalin (ibritumomab tiuxetan) for the treatment of patients with previously untreated follicular non-Hodgkin's lymphoma.
Adding coronary artery calcium score testing with CT in patients with a normal SPECT scan could help to identify those at high long-term risk for cardiac events, in whom an earlier focus on aggressive risk factor modification and other medical therapies may be beneficial, according to new findings published in the Nov. 10 issue of the Journal of the American College of Cardiology.
Dublin, Ohio-based Neoprobe has posted its 2009 third quarter results, showing a net loss of more than $25 million.
PET imaging of non-small cell lung cancer prior to receiving radiation therapy should not be the basis for determining areas that may benefit from higher doses of radiation, according to research presented today by investigators at the 51st American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
|